Propantheline Bromide | CAS#50-34-0 | CAS#298-50-0 | Muscarinic Acetylcholine Receptor Antagonist

MedKoo Cat#: 318584 | Name: Propantheline Bromide

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Propantheline bromide inhibits action of acetylcholine at post-ganglionic synapses and acts as a muscarinic acetylcholine receptor antagonist, antispasmodic, and reduces gastric acid secretion. At high doses it has nicotinic effects resulting in neuromuscular blocking. Propantheline bromide competitively antagonizes acetylcholine activity mediated by muscarinic receptors at neuroeffector sites on smooth muscle and exocrine gland cells.

Chemical Structure

Propantheline Bromide

CAS#50-34-0 (Br)

Theoretical Analysis

MedKoo Cat#: 318584

Name: Propantheline Bromide

CAS#: 50-34-0 (Br)

Chemical Formula: C23H30BrNO3

Exact Mass:

Molecular Weight: 448.39

Elemental Analysis: C, 61.61; H, 6.74; Br, 17.82; N, 3.12; O, 10.70

Price and Availability

Size	Price	Availability	Quantity
2g	USD 350.00	2 Weeks
10g	USD 950.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

50-34-0 (Br) 298-50-0 (free)

Synonym

Propantheline Bromide; Pro-Banthine; Neometantyl; Neopepulsan; Pantheline

IUPAC/Chemical Name

methyl-di(propan-2-yl)-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium;bromide

InChi Key

XLBIBBZXLMYSFF-UHFFFAOYSA-M

InChi Code

InChI=1S/C23H30NO3.BrH/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22;/h6-13,16-17,22H,14-15H2,1-5H3;1H/q+1;/p-1

SMILES Code

CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C.[Br-]

Appearance

White to light yellow solid powder.

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO, not in water

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 448.39 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Gyldenløve M, Thyssen JP. [Propantheline bromide is effective against dog drooling]. Ugeskr Laeger. 2015 Dec 21;177(52). pii: V67934. Danish. PubMed PMID: 26692220. 2: Abd El-Rahman MK, Zaazaa HE, Badr ElDin N, Moustafa AA. Novel strategy for online monitoring of the degradation kinetics of propantheline bromide via a calixarene-based ion-selective electrode. Talanta. 2015 Jan;132:52-8. doi: 10.1016/j.talanta.2014.08.068. Epub 2014 Sep 6. PubMed PMID: 25476278. 3: Baraldi C, Freguglia G, Tinti A, Sparta M, Alexandrova AN, Gamberini MC. IR, Raman and SERS spectra of propantheline bromide. Spectrochim Acta A Mol Biomol Spectrosc. 2013 Feb 15;103:1-10. doi: 10.1016/j.saa.2012.10.070. Epub 2012 Nov 7. PubMed PMID: 23228825. 4: Yu JC, Sung RJ. Clinical efficacy of propantheline bromide in neurocardiogenic syncope: pharmacodynamic implications. Cardiovasc Drugs Ther. 1997 Jan;10(6):687-92. PubMed PMID: 9110111. 5: Jansen T, Plewig G, Hölzle E. [Allergic contact dermatitis due to propantheline bromide]. Dtsch Med Wochenschr. 1996 Jan 5;121(1-2):41-2. German. PubMed PMID: 8565805. 6: Heckerling PS, Ammar KA. Bromide intoxication due to propantheline bromide. Am J Nephrol. 1996;16(6):537-9. PubMed PMID: 8955768. 7: Daniels R, Rupprecht H. Adsorption and chemical stability of a cationic aggregating ester - propantheline bromide - on silica surfaces in aqueous dispersions. Pharm Res. 1985 Jul;2(4):170-5. doi: 10.1023/A:1016336005391. PubMed PMID: 24272808. 8: Kountourellis JE, Raptouli A. X-ray powder diffraction data for propantheline bromide. Acta Pharm Suec. 1985;22(1):59-61. PubMed PMID: 4024969. 9: Cox SR, Harrington EL, Capponi VJ. Bioavailability studies with ciglitazone in beagles. II. Effect of propantheline bromide and metoclopramide HCL on bioavailability of a tablet. Biopharm Drug Dispos. 1985 Jan-Mar;6(1):81-90. PubMed PMID: 3986303. 10: Ford BL, Wall AK, Johnston MA, Lea AR. Identification of a propantheline analog in propantheline bromide tablets. J Assoc Off Anal Chem. 1984 Sep-Oct;67(5):934-9. PubMed PMID: 6501158. 11: Hongo M, Traube M, McCallum RW. Comparison of effects of nifedipine, propantheline bromide, and the combination on esophageal motor function in normal volunteers. Dig Dis Sci. 1984 Apr;29(4):300-4. PubMed PMID: 6705640. 12: Charles BG, Ravenscroft PJ, Jacobsen NW. Analysis of propantheline bromide in serum by high-performance liquid chromatography. J Chromatogr. 1984 Mar 9;306:424-8. PubMed PMID: 6715483. 13: Moses DK, Charles BG, Ravenscroft PJ, Whyte IM. Food reduces the oral bioavailability of propantheline bromide in healthy subjects. Br J Clin Pharmacol. 1983 Dec;16(6):758-9. PubMed PMID: 6661368; PubMed Central PMCID: PMC1428342. 14: Rigby GV, Vose CW, Haskins NJ, Allan EF, Harrison IR, Shelton JR, Brownsill RD, Perkins RM, Ford GC, Hawkins AJ, et al. Propantheline bromide plasma level, urinary excretion and pharmacological data in a comparison of the bioavailability of three oral formulations of Pro-Banthine. Eur J Drug Metab Pharmacokinet. 1983 Jul-Sep;8(3):219-24. PubMed PMID: 6689152. 15: Davis BM, Mathé AA, Mohs RC, Levy MI, Davis KL. Effects of propantheline bromide on basal growth hormone, cortisol and prolactin levels. Psychoneuroendocrinology. 1983;8(1):103-7. PubMed PMID: 6683853. 16: Grijalva CV, Novin D, Cooper PH. Facilitation of recovery by propantheline bromide after lateral hypothalamic damage. Brain Res Bull. 1980 Sep-Oct;5(5):525-9. PubMed PMID: 7427753. 17: Duane WC, Bond JH Jr. Prolongation of intestinal transit and expansion of bile acid pools by propantheline bromide. Gastroenterology. 1980 Feb;78(2):226-30. PubMed PMID: 7350044. 18: Dajani EZ, Bianchi RG, Calhoun DW. Synergistic actions of propantheline bromide with cimetidine and thiopropazate hydrochloride in the prevention of stress ulcer formation in rats. J Pharmacol Exp Ther. 1979 Sep;210(3):373-7. PubMed PMID: 573317. 19: Brannon WL, Benson WR, Smith MM. Identification tests for propantheline bromide. J Assoc Off Anal Chem. 1979 Jul;62(4):808-11. PubMed PMID: 500531. 20: Vose CW, Ford GC, Grigson SJ, Haskins NJ, Prout M, Stevens PM, Rose DA, Palmer RF, Rudel H. Pharmacokinetics of propantheline bromide in normal man. Br J Clin Pharmacol. 1979 Jan;7(1):89-93. PubMed PMID: 760746; PubMed Central PMCID: PMC1429618.